Skip to main content

Table 6 Volunteer typical daily dietary intake whilst consuming the placebo and treatment bread products

From: A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers

  Calories Protein Fat Carbohydrate Fibre Non starch polysaccharides Iron
(kcal) (g) (g) (g) (g) (g) (mg)
placebo 1796.0 68.1 53.8 227.5 19.8 14.9 12.9
treatment ±726.1 ±31.2 ±25.2 ±110.5 ±7.9 ±6.0 ±8.5
AXOS 1900.3 73.6 64.1 227.2 18.9 14.4 11.2
treatment ±767.5 ±53.0 ±27.4 ±127.3 ±5.7 ±4.3 ±3.9
  1. (Average consumption from 4 consecutive days).